Research Article

Salidroside Alleviates Myocardial Ischemia Reperfusion by Balancing Mitochondrial Homeostasis via Nrf2

Figure 1

Myocardial protection by SAL against H/R. (a, b) Cell viability of H9c2 cells treated with SAL (0–1600 μM). (c–e) The AST, CTn-T, and LDH release of H9c2 cells treated with SAL (50–100 μM) followed by H/R stimulation. Values are presented as mean ± SEM. versus the control group; and versus the H/R group.
(a)
(b)
(c)
(d)
(e)